Risk Factors for Ocular Complications and Visual Loss in Patients with Juvenile Idiopathic Arthritis-associated Uveitis at a Turkish Tertiary Ophthalmology and Pediatric Rheumatology Referral Center

References

• Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2003;14(6):395–398. doi:10.1097/00055735-200312000-00013.
   PubMedGoogle Scholar
• Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K, German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology. 2007;46(6):1015–1019. doi:10.1093/rheumatology/kem053.
   PubMed Web of Science ®Google Scholar
• Yalçındağ FN, Özdal PC, Özyazgan Y, Batıoğlu F, Tugal-Tutkun I, BUST Study Group. Demographic and clinical characteristics of Uveitis in Turkey: the first national registry report. Ocul Immunol Inflamm. 2018;26(1):17–26. doi:10.1080/09273948.2016.1196714.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Woreta F, Kedhar F, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143(5):840–846. doi:10.1016/j.ajo.2007.01.033.
   PubMed Web of Science ®Google Scholar
• Gregory AC 2nd, Kempen JH, Daniel E, et al. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic immunosuppressive therapy for eye diseases study. systemic immunosuppressive therapy for eye diseases cohort study research group. Ophthalmology. 2013;120(1):186–192. doi:10.1016/j.ophtha.2012.07.052.
   PubMed Web of Science ®Google Scholar
• Paroli MP, Abbouda A, Restivo L, Sapia A, Abicca I, Pezzi-Pivetti P. Juvenile idiopathic arthiritis –associated uveitis at an Italian tertiary referral center: clinical features and complications. Ocul Immunol Inflamm. 2015;23(1):74–81. doi:10.3109/09273948.2013.855798.
   PubMed Web of Science ®Google Scholar
• Woreta F, Thorne JE, Jabs DA, et al. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143(4):647–655. doi:10.1016/j.ajo.2006.11.025.
   PubMed Web of Science ®Google Scholar
• Angles-Han ST, Ringold S, Beukelman T, et al. American College of Rheumatology/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken). 2019;71(6):703–716. doi:10.1002/acr.23871.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Pelajo CF, Vogler LB, et al. Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. J Rheumatol. 2013;40(12):2088–2096. doi:10.3899/jrheum.130302.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Klotsche J, Tappeiner C, et al. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the inception cohort of newly diagnosed patients with Juvenile idiopathic arthritis (ICON-JIA) study. Rheumatology (Oxford). 2019;58(6):975–986. doi:10.1093/rheumatology/key406.
   PubMed Web of Science ®Google Scholar
• Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–392.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group: standardization of uveitis nomenclature for reporting clinical data. (Results of the first international workshop). Am J Ophthalmol. 2005;140:509–551.
   PubMed Web of Science ®Google Scholar
• Rypadal V, Glerup M, Songstad NT, et al. Uveitis in juvenile idiopathic arthritis 18-year outcome in the population-based Nordic cohort study. Ophthalmology. 2021;128(4):598–608. doi:10.1016/j.ophtha.2020.08.024.
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J. Impact of antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a nationwide pediatric rheumatology database. Arthritis Care Res. 2016;68(1):46–54. doi:10.1002/acr.22649.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Mingels A, Heinz C, et al. Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophthalmol. 2007;17(5):743–748. doi:10.1177/112067210701700509.
   PubMed Web of Science ®Google Scholar
• Castagna I, Rooszkowska M, Alessandrello F, et al. Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy. Int Ophthalmol. 2020;40(2):335–342. doi:10.1007/s10792-019-01184-8.
   PubMed Web of Science ®Google Scholar
• Simonini G, Paudyal P, Jones GT, Cimaz R, MAcfarlane GJ. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology. 2013;52(5):825–831. doi:10.1093/rheumatology/kes186.
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Eng J Med. 2017;376(17):1637–1646. doi:10.1056/NEJMoa1614160.
   PubMed Web of Science ®Google Scholar
• Tirelli F, Zannin ME, Vittadello F, Agnolucci J, Mazzarolo M, Zulian F. Methotrexate monotherapy in juvenile idiopathic arthritis associated uveitis: myth or reality? Ocul Immunol Inflamm. 2021 Jul 20:1–5. Online ahead of print. doi:10.1080/09273948.2021.1951303.
   PubMed Web of Science ®Google Scholar
• Maccora I, Fusco E, Marrani E, Ramanan AV, Simonini G. Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis. Rheumatology (Oxford). 2021;60(2):567–568. doi:10.1093/rheumatology/keaa595.
   Web of Science ®Google Scholar
• Kolomeyer AM, Tu Y, Miserocchi E, Ranjan M, Davidow A, Chu DS. Chronic non-infectious uveitis in patients with juvenile idiopathic arthritis. Ocul Immunol Inflamm. 2016;24(4):377–385. doi:10.3109/09273948.2015.1125509.
   PubMed Web of Science ®Google Scholar
• Lerman MA, Burnham JM, Chang PY, et al. Response of pediatric uveitis to tumor necrosis factor-α inhibitors. J Rheumatol. 2013;40(8):1394–1403. doi:10.3899/jrheum.121180.
   PubMed Web of Science ®Google Scholar
• Doycheva D, Zierhut M, Blumenstock G, et al. Immunomodulatory therapy with tumour necrosis factor a inhibitors in children with antinuclear antibody associated chronic anterior uveitis long-term results. Br J Ophthalmol. 2014;98(4):523–528. doi:10.1136/bjophthalmol-2013-303935.
   PubMed Web of Science ®Google Scholar
• Cecchin V, Zannin ME, Ferrari D, et al. Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2018;45(8):1167–1172. doi:10.3899/jrheum.171006.
   PubMed Web of Science ®Google Scholar
• Ayuso VK, Ten Cate HA, van der Does P, Rothova A, de Boer JH. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149(6):987–993. doi:10.1016/j.ajo.2010.01.014.
   PubMed Web of Science ®Google Scholar
• Vitale AT, Graham E, de Boer JH. Juvenile idiopathic arthritis-associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome. Ocul Immunol Inflamm. 2013;2186(6):478–485. doi:10.3109/09273948.2013.815785.
   Google Scholar